Total Funding
3
Total FundingSeries A raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
63704
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Acquired by 
Century Therapeutics
- Derek Hei: CTOPast Role: BlueRock Therapeutics, Chief of Manufacturing & Technical Operations
- Leandro Vetcher: Chief Operating Officer, Co-FounderPast Role: Kosan Biosciences, Researcher
About the Company
Clade Therapeutics is a biopharmaceutical company focused on discovering and delivering scalable, off-the-shelf, next-generation stem-cell-based medicines.
The company was incorporated in 2020 and has been operating in Cambridge, Massachusetts, United States.
